Skip to main content
. 2020 Feb 15;11(4):918–927. doi: 10.1111/1759-7714.13340

Figure 4.

Figure 4

(a) The DFS analysis in patients with squamous cell carcinoma (P < 0.001). (b) The OS analysis in patients with squamous cell carcinoma (P < 0.001). (c) The DFS analysis in patients with adenocarcinoma (P = 0.001). (d) The OS analysis in patients with adenocarcinoma (P = 0.001). Inline graphic≤12.65, Inline graphic>12.65. PDW, platelet distribution width; DFS, disease‐free survival; OS, overall survival.